Literature DB >> 5160528

The role of prosthetic replacement of the head of the femur as primary treatment for subcapital fractures.

H R Lung.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5160528

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


× No keyword cloud information.
  8 in total

1.  [Prevention of infection in implantation of femur head prostheses].

Authors:  O Kwasny; W Scharf; M Schemper
Journal:  Langenbecks Arch Chir       Date:  1989

2.  [Results before and after introduction of perioperative antibiotic prophylaxis in hip joint prostheses treatment of geriatric patients].

Authors:  W Kaiser; V Gulielmos; H Hausmann; S Ghalehasadi
Journal:  Unfallchirurgie       Date:  1996-08

3.  Fractures of the neck of the femur. A prospective study of the early results.

Authors:  J P McElwaine; J Curtin; R O'Brien
Journal:  Ir J Med Sci       Date:  1980-12       Impact factor: 1.568

4.  The Thompson prosthesis in the treatment of subcapital fractures of the neck of the femur.

Authors:  A J Tonino
Journal:  Int Orthop       Date:  1982       Impact factor: 3.075

5.  Risk Factor Analysis for 30-Day Mortality After Primary THA in a Single Institution.

Authors:  Fernando Comba; Ignacio Alonso Hidalgo; Martín Buttaro; Francisco Piccaluga
Journal:  HSS J       Date:  2012-06-30

6.  The value of a special surgical team in preventing complications in the treatment of hip fractures.

Authors:  M J Parker; G A Pryor; J W Myles
Journal:  Int Orthop       Date:  1994-06       Impact factor: 3.075

7.  Mortality and morbidity associated with hip fractures.

Authors:  D P Moore; W Quinlan
Journal:  Ir J Med Sci       Date:  1989-02       Impact factor: 1.568

8.  Low femoral antetorsion as a risk factor for bony impingement after bipolar hemiarthroplasty.

Authors:  Takeshi Shoji; Yuji Yasunaga; Takuma Yamasaki; Soutarou Izumi; Susumu Hachisuka; Mitsuo Ochi
Journal:  J Orthop Surg Res       Date:  2015-07-07       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.